De Novo DSA in the Setting of Stable Renal Allograft Function is a Benign Finding

被引：2
|
作者：
Knight, Richard [1 ]
Eagar, Todd [2 ]
Duc Nguyen [2 ]
Graviss, Edward [2 ]
Kuten, Samantha [3 ]
Patel, Samir [3 ]
Moore, Linda [1 ]
Gaber, Osama [1 ]
机构：
[1] Houston Methodist Hosp, Surg, Houston, TX USA
[2] Houston Methodist Hosp, Pathol & Genom Med, Houston, TX USA
[3] Houston Methodist Hosp, Pharm, Houston, TX USA
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
10.1097/01.tp.0000542596.39174.b7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
318.7
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] De Novo DSA in the Setting of Stable Allograft Function is a Benign Finding.
    Knight, R. J.
    Graviss, E. A.
    Nguyen, D. T.
    Eagar, T. N.
    Yi, S. G.
    Podder, H.
    Hobeika, M.
    McMillan, R.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 707 - 708
  • [2] De Novo DSA in the Setting of Stable Renal Allograft Function Does Not Impair Long-Term Graft Survival
    Knight, R.
    Nguyen, D. T.
    Graviss, E. A.
    Gaber, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 860 - 860
  • [3] Long Term Outcomes of Renal Allografts with De Novo DSA in the Setting of Stable Graft Function versus Acute Rejection.
    Knight, R.
    Nguyen, D.
    Graviss, E.
    Eagar, T.
    Kuten, S.
    Patel, S.
    Moore, L.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 774 - 774
  • [4] Temporal Relationship between De Novo DSA and Allograft Dysfunction in Renal Transplant Patients
    Wu, P.
    Everly, M. J.
    Rebellato, L. M.
    Ozawa, M.
    Briley, K. P.
    Catrou, P. G.
    Bolin, P.
    Kendrick, W. T.
    Kendrick, S.
    Haisch, C. E.
    Harland, R. C.
    Terasaki, P. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 168 - 169
  • [5] De novo Angiosarcoma of a Renal Allograft
    Ferroni, Matthew C.
    Ristau, Benjamin T.
    Jackman, Stephen V.
    UROLOGIA INTERNATIONALIS, 2015, 95 (03) : 367 - 369
  • [6] Changes in Successive Measures of De Novo DSA Intensity Predict Development of Renal Allograft Dysfunction.
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Harland, R.
    Terasaki, P.
    TRANSPLANTATION, 2014, 98 : 511 - 512
  • [7] Changes in Successive Measures of De Novo DSA Intensity Predict Development of Renal Allograft Dysfunction.
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Harland, R.
    Terasaki, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 511 - 512
  • [8] The Impact of De Novo HLA DQ DSA in Kidney Allograft Rejection
    Freitas, M. C. S.
    Ozawa, M.
    Nguyen, A.
    Sasaki, N.
    Everly, M. J.
    Rebellato, L. M.
    Terasaki, P. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 412 - 413
  • [9] De novo AL amyloid in a renal allograft
    Le, QC
    Wood, TC
    Alpers, CE
    AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (01) : 67 - 70
  • [10] De Novo IgA Nephropathy in a Renal Allograft
    Shabaka, Amir
    Perez-Flores, Isabel
    Antonio Cortes, Jose
    Isabel Sanchez-Fructuoso, Ana
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 (04) : 550 - 553
12345